最新报道:Mei Pharma has announced a $100 million investment in Ethereum and Litecoin, signaling growing institutional interest in cryptocurrencies. The pharmaceutical company's move highlights the increasing convergence of traditional industries with digital assets. This investment comes amid a broader institutional crypto surge, with major firms allocating more capital to established cryptocurrencies like Ethereum and Litecoin. Analysts view this as a significant validation of crypto's role in corporate treasury strategies, particularly for companies outside the financial sector. The investment is expected to further legitimize cryptocurrency adoption among institutional investors seeking portfolio diversification.